Sargent Bickham Lagudis’s NeoGenomics NEO Stock Holding History

Sargent Bickham Lagudis’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-650	Closed	-$22K	–	998
2021 Q4	$22K	Hold	650	–	–	﹤0.01%	585
2021 Q3	$31K	Hold	650	–	–	﹤0.01%	531
2021 Q2	$29K	Hold	650	–	–	﹤0.01%	553
2021 Q1	$31K	Hold	650	–	–	﹤0.01%	517
2020 Q4	$35K	Buy	+650	New	+$29.4K	﹤0.01%	474

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Sargent Bickham Lagudis's NEO Position: Q1 2022 in Review

Sargent Bickham Lagudis sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 650 shares — an estimated $22K sold.

Sargent Bickham Lagudis first reported a position in NEO in Q4 2020 and held it in 5 quarters. The position peaked at $35K in Q4 2020. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

Sargent Bickham Lagudis reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
Sargent Bickham Lagudis sold 650 NeoGenomics shares in Q1 2022, an estimated $22K.
Sargent Bickham Lagudis first reported a position in NeoGenomics in Q4 2020 and held it in 5 quarters.
Sargent Bickham Lagudis's NeoGenomics position peaked at $35K in Q4 2020.
279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q1 2022, filed 27 Apr 2022.